AKAN
Akanda Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$3.22
+9.52%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$3.29
From 52W high−96.62%
Volume9.41M
Market cap$1.74M
P/E (TTM)—
P/S (TTM)6.7x
Div yield—
Key dataSep 18, 2026
Open
$3.29
From 52W high
−96.62%
Volume
9.41M
Market cap
$1.74M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.9x
P/E (TTM)
—
RSI (14)
37.3
MomentumView details →
1D Return
+9.52%
YTD Return
−65.72%
SummaryUpdated Dec 1, 2025
Akanda Corp. (NASDAQ:AKAN) is a cannabis cultivation, manufacturing, and distribution company founded in 2021 and headquartered in New Romney, United Kingdom. The company went public in March 2022 and operates primarily in the United Kingdom and Lesotho, focusing on the production and distribution of medical cannabis and wellness products. Since its inception, Akanda has been working to establish itself in the emerging global medical cannabis market, though it has faced significant operational and financial challenges in its early years as a public company.
Similar companies
Latest newsMore news →
Akanda Corp.'s subsidiary First Towers & Fiber Corp. delivered an operational and expansion update on Friday.37d agoAkanda Corp.'s subsidiary First Towers & Fiber Corp. completed a 200 km fiber network in Mexico, increasing recurring revenue.38d agoAkanda Corp. received a Nasdaq notice for non-compliance with the minimum stockholders' equity requirement.94d ago